Soraya Abbasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Soraya Abbasi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Vinod K. Bhutani
Lucile Salter Packard Children’s Hospital, Stanford Children’s Health, Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, USA
6 shared publications Emidio M Sivieri
Div. Patologia Neonatale e Terapia Intensiva, Policlinico San Matteo IRCCS, Pavia, Italy, Dept. of Pediatrics, Jefferson Medical College and Section on Newborn Pediatrics, Pennsylvania Hospital, Philadelphia, PA. USA.
5 shared publicationsJeffrey S. Gerdes
Section on Newborn Pediatrics, Pennsylvania Hospital, Philadelphia, Pennsylvania
4 shared publicationsEmidio M. Sivieri
Section on Newborn Pediatrics, Pennsylvania Hospital, Philadelphia, Pennsylvania, USA
3 shared publicationsJeffrey Gerdes
2 shared publicationsAida Bairam
Department of Pediatrics, Laval University, Quebec City, Canada
1 shared publication
Latest Publications
- 2 September 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 178, 288-291.e2
Effects of Targeting Higher or Lower Oxygen Saturations in Centers with More Versus Less Separation between Median Saturations
- 2 September 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 178, 288-291.e2
Effects of Targeting Higher or Lower Oxygen Saturations in Centers with More Versus Less Separation between Median Saturations
- 23 July 2012
- Published by Wiley in Pediatric Pulmonology
- Vol. 48 (5) , 506-514
Effect of HFNC flow rate, cannula size, and nares diameter on generated airway pressures: An in vitro study
Increased use of non‐invasive forms of respiratory support such as CPAP and HFNC in premature infants has generated a need for further investigation of the pulmonary effects of such therapies. In a series of in vitro tests, we measured delivered proximal airway pressures from a HFNC system while varying both the cannula flow and the ratio of nasal prong to simulated nares diameters. Neonatal and infant sized nasal prongs (3.0 and 3.7 mm O.D.) were inserted into seven sizes of simulated nares (range: 3–7 mm I.D. from anatomical measurements in 1–3 kg infants) for nasal prong‐to‐nares ratios ranging from 0.43 to 1.06. The nares were connected to an active test lung set at: TV 10 ml, 60 breaths/min, Ti 0.35 sec, compliance 1.6 ml/cm H2O and airway resistance 70 cm H2O/(L/sec), simulating a 1–3 kg infant with moderately affected lungs. A Fisher & Paykel Healthcare HFNC system with integrated pressure relief valve was set to flow rates of 1–6 L/min while cannula and airway pressures and cannula and mouth leak flows were measured during simulated mouth open, partially closed and fully closed conditions.Airway pressure progressively increased with both increasing HFNC flow rate and nasal prong‐to‐nares ratio. At 6 L/min HFNC flow with mouth open, airway pressures remained 2O for all ratios; and 2O with mouth closed for ratios 0.9 and 50% mouth leak, airway pressures rapidly increased to 18 cm H2O at 2 L/min HFNC flow followed by a pressure relief valve limited increase to 24 cm H2O at 6 L/min.Safe and effective use of HFNC requires careful selection of an appropriate nasal prong‐to‐nares ratio even with an integrated pressure relief valve. Pediatr Pulmonol. 2013; 48:506–514.
- 23 July 2012
- Published by Wiley in Pediatric Pulmonology
- Vol. 48 (5) , 506-514
Effect of HFNC flow rate, cannula size, and nares diameter on generated airway pressures: An in vitro study
Increased use of non‐invasive forms of respiratory support such as CPAP and HFNC in premature infants has generated a need for further investigation of the pulmonary effects of such therapies. In a series of in vitro tests, we measured delivered proximal airway pressures from a HFNC system while varying both the cannula flow and the ratio of nasal prong to simulated nares diameters. Neonatal and infant sized nasal prongs (3.0 and 3.7 mm O.D.) were inserted into seven sizes of simulated nares (range: 3–7 mm I.D. from anatomical measurements in 1–3 kg infants) for nasal prong‐to‐nares ratios ranging from 0.43 to 1.06. The nares were connected to an active test lung set at: TV 10 ml, 60 breaths/min, Ti 0.35 sec, compliance 1.6 ml/cm H2O and airway resistance 70 cm H2O/(L/sec), simulating a 1–3 kg infant with moderately affected lungs. A Fisher & Paykel Healthcare HFNC system with integrated pressure relief valve was set to flow rates of 1–6 L/min while cannula and airway pressures and cannula and mouth leak flows were measured during simulated mouth open, partially closed and fully closed conditions.Airway pressure progressively increased with both increasing HFNC flow rate and nasal prong‐to‐nares ratio. At 6 L/min HFNC flow with mouth open, airway pressures remained 2O for all ratios; and 2O with mouth closed for ratios 0.9 and 50% mouth leak, airway pressures rapidly increased to 18 cm H2O at 2 L/min HFNC flow followed by a pressure relief valve limited increase to 24 cm H2O at 6 L/min.Safe and effective use of HFNC requires careful selection of an appropriate nasal prong‐to‐nares ratio even with an integrated pressure relief valve. Pediatr Pulmonol. 2013; 48:506–514.
- 1 July 2012
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 13 (4) , e262-e268
Accuracy of tidal volume, compliance, and resistance measurements on neonatal ventilator displays
Objective: To determine the accuracy of measures of respiratory mechanics derived from neonatal ventilators using an in vitro passive physical lung model to simulate newborn pulmonary conditions. Design: Test lung models. Setting: Laboratory-based measurements. Interventions: Three test lungs were constructed to simulate three severities of neonatal lung disease, with ranges of compliance from 0.5 to 2.0 mL/cm H2O and resistance from 25 to 150 cm H2O/(L/sec). Each ventilator was tested using 27 combinations of peak inspiratory pressure (15–25 cm H2O), positive end-expiratory pressure (5–7 cm H2O), and rate settings (20–60 B/min). Data were compared for five different ventilators across simulated lung severity as the ratio of ventilator readout to test lung reference value. A ratio of 1.0 indicated a completely unbiased result. Main Results: Overall, four of the five ventilators under-read expired tidal volume by about 1%–12% across all lung conditions, whereas the VIP Bird readout ranged from −4% to +4% bias. Changes in ventilator settings had only a modest effect on mechanics readout. As peak inspiratory pressure progressed from 15 to 25 cm H2O, bias in tidal volume readout changed from +5.0% to −2.5% (p < .001) in the VIP Bird, and from −11% to −9% (p < .001) in the Draeger Babylog VN500. Between positive end-expiratory pressure levels of 5 and 7 cm H2O, tidal volume bias in the Babylog varied between −13% and −7% (p < .001). In progressing from simulated normal to severely ill lung condition, bias in compliance measurements by the Avea and SLE5000 increased from −18% to −40% whereas in the VIP Bird it remained between −17% to −13%, and in the Draeger Evita XL-neo it changed from +17% to −13% and from −8% to −16% in the Babylog. Ratio of ventilator resistance readout to reference value with progressing simulated lung condition changed from 2.0 to 1.0 for the Draeger Evita, 1.6 to 1.1 for the Babylog, 4.2 to 2.0 for the SLE, and from 11.7 to 5.6 for the VIP Bird. The Avea, by design, did not display resistances >100 cm H2O/(L/sec), but overestimated the simulated normal lung resistance of 25 cm H2O/(L/sec) by a factor of 2.5. Conclusions: Neonatal ventilator respiratory mechanics measurements and computation methods need further standardization to be useful in clinical settings.
- 1 July 2012
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 13 (4) , e262-e268
Accuracy of tidal volume, compliance, and resistance measurements on neonatal ventilator displays
Objective: To determine the accuracy of measures of respiratory mechanics derived from neonatal ventilators using an in vitro passive physical lung model to simulate newborn pulmonary conditions. Design: Test lung models. Setting: Laboratory-based measurements. Interventions: Three test lungs were constructed to simulate three severities of neonatal lung disease, with ranges of compliance from 0.5 to 2.0 mL/cm H2O and resistance from 25 to 150 cm H2O/(L/sec). Each ventilator was tested using 27 combinations of peak inspiratory pressure (15–25 cm H2O), positive end-expiratory pressure (5–7 cm H2O), and rate settings (20–60 B/min). Data were compared for five different ventilators across simulated lung severity as the ratio of ventilator readout to test lung reference value. A ratio of 1.0 indicated a completely unbiased result. Main Results: Overall, four of the five ventilators under-read expired tidal volume by about 1%–12% across all lung conditions, whereas the VIP Bird readout ranged from −4% to +4% bias. Changes in ventilator settings had only a modest effect on mechanics readout. As peak inspiratory pressure progressed from 15 to 25 cm H2O, bias in tidal volume readout changed from +5.0% to −2.5% (p < .001) in the VIP Bird, and from −11% to −9% (p < .001) in the Draeger Babylog VN500. Between positive end-expiratory pressure levels of 5 and 7 cm H2O, tidal volume bias in the Babylog varied between −13% and −7% (p < .001). In progressing from simulated normal to severely ill lung condition, bias in compliance measurements by the Avea and SLE5000 increased from −18% to −40% whereas in the VIP Bird it remained between −17% to −13%, and in the Draeger Evita XL-neo it changed from +17% to −13% and from −8% to −16% in the Babylog. Ratio of ventilator resistance readout to reference value with progressing simulated lung condition changed from 2.0 to 1.0 for the Draeger Evita, 1.6 to 1.1 for the Babylog, 4.2 to 2.0 for the SLE, and from 11.7 to 5.6 for the VIP Bird. The Avea, by design, did not display resistances >100 cm H2O/(L/sec), but overestimated the simulated normal lung resistance of 25 cm H2O/(L/sec) by a factor of 2.5. Conclusions: Neonatal ventilator respiratory mechanics measurements and computation methods need further standardization to be useful in clinical settings.
- 11 November 2010
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 28 (01) , 087-088
Errata “Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants”
The publisher regrets an error in the table titles of Tables [ 1 ] and [ 2 ] in the above article in the American Journal of Perinatology, Volume 27, Number 1, 2010, p. 63. The correct tables appear below. Table 1 Maternal and Delivery Characteristics of Singleton Pregnancies Delivered at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Maternal age (y) 28.7 ± 7.1 26.9 ± 7.2 0.22 Black/white/other (%) 65/23/13 66/17/17 0.90 Preeclampsia (%) 9.8 2.9 0.37 Preterm labor (%) 77.8 68.9 0.61 Chorioamnionitis (%) 76.8 54.3 0.03 Premature rupture of membranes (%) 59.8 34.3 0.02 Cesarean section (%) 47.6 40.0 0.58 Gestational age at ANS dose (wk) 23.5 ± 0.5 Data expressed as percentage and mean ± standard deviation. ANS, antenatal corticosteroid. Table 2 Antenatal Corticosteroid Exposure: Outcome of Singleton Infants at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Birth weight (g) 702 ± 165 657 ± 150 0.14 Gestational age (wk) 24.3 ± 1.0 24.1 ± 1.1 0.30 Sex (% male/female) 54.9/45.1 57.1/42.9 0.84 1-min Apgar <7 (%) 68.3 88.6 0.02 5-min Apgar <7 (%) 30.5 51.4 0.03 Death before discharge (%) 29.3 62.9 <0.001 IVH (grade 1 and 2, %) 45.5 43.5 0.99 IVH (grade 3 and 4, %) 16.7 36.0 <0.05 RDS (%) 100 100 NA PDA treated with indomethacin (%) 50.7 72.0 0.07 Sepsis (%) 60.7 52.2 0.48 NEC stage 3 and 4 (%) 0.0 6.9 0.57 Pressors (%) 54.4 64.5 0.35 ROP (stage 3–4) 32.7 23.1 0.74 BPD at 36 weeks' PCA (%) 71.9 76.9 0.99 Duration of vent (d) 51 ± 37 49 ± 21 0.80 Duration of O2 (d) 55 ± 38 53 ± 38 0.72 Length of stay (d) 117 ± 52 108 ± 24 0.41 Data expressed as percentage and mean ± SD. PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; PCA, postconceptional age.
- 11 November 2010
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 28 (01) , 087-088
Errata “Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants”
The publisher regrets an error in the table titles of Tables [ 1 ] and [ 2 ] in the above article in the American Journal of Perinatology, Volume 27, Number 1, 2010, p. 63. The correct tables appear below. Table 1 Maternal and Delivery Characteristics of Singleton Pregnancies Delivered at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Maternal age (y) 28.7 ± 7.1 26.9 ± 7.2 0.22 Black/white/other (%) 65/23/13 66/17/17 0.90 Preeclampsia (%) 9.8 2.9 0.37 Preterm labor (%) 77.8 68.9 0.61 Chorioamnionitis (%) 76.8 54.3 0.03 Premature rupture of membranes (%) 59.8 34.3 0.02 Cesarean section (%) 47.6 40.0 0.58 Gestational age at ANS dose (wk) 23.5 ± 0.5 Data expressed as percentage and mean ± standard deviation. ANS, antenatal corticosteroid. Table 2 Antenatal Corticosteroid Exposure: Outcome of Singleton Infants at 230/7 to 256/7 Weeks' Gestation Characteristics Steroid-Treated (n = 82) Controls (n = 35) p Value Birth weight (g) 702 ± 165 657 ± 150 0.14 Gestational age (wk) 24.3 ± 1.0 24.1 ± 1.1 0.30 Sex (% male/female) 54.9/45.1 57.1/42.9 0.84 1-min Apgar <7 (%) 68.3 88.6 0.02 5-min Apgar <7 (%) 30.5 51.4 0.03 Death before discharge (%) 29.3 62.9 <0.001 IVH (grade 1 and 2, %) 45.5 43.5 0.99 IVH (grade 3 and 4, %) 16.7 36.0 <0.05 RDS (%) 100 100 NA PDA treated with indomethacin (%) 50.7 72.0 0.07 Sepsis (%) 60.7 52.2 0.48 NEC stage 3 and 4 (%) 0.0 6.9 0.57 Pressors (%) 54.4 64.5 0.35 ROP (stage 3–4) 32.7 23.1 0.74 BPD at 36 weeks' PCA (%) 71.9 76.9 0.99 Duration of vent (d) 51 ± 37 49 ± 21 0.80 Duration of O2 (d) 55 ± 38 53 ± 38 0.72 Length of stay (d) 117 ± 52 108 ± 24 0.41 Data expressed as percentage and mean ± SD. PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; PCA, postconceptional age.
- 31 July 1999
- Published by Elsevier in The Journal of Pediatrics
- Vol. 135 (1) , 135-136
Reply
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 134
Effects of Antenatal Magnesium Exposure on Neonatal Mortality and Morbidity.† 789
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 134
Effects of Antenatal Magnesium Exposure on Neonatal Mortality and Morbidity.† 789
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 56
Pulmonary Function and Electrolyte Balance Following Spironolactone Treatment in Preterm Infants with Chronic Lung Disease. • 321
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 56
Pulmonary Function and Electrolyte Balance Following Spironolactone Treatment in Preterm Infants with Chronic Lung Disease. • 321
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 351
EFFECTS OF MULTIPLE AND SERIAL BRONCHIAL-ALVEOLAR LAVAGE SAMPLING ON HEMODYNAMIC AND PULMONARY STATUS OF VLBW INFANTS. 2091
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 351
EFFECTS OF MULTIPLE AND SERIAL BRONCHIAL-ALVEOLAR LAVAGE SAMPLING ON HEMODYNAMIC AND PULMONARY STATUS OF VLBW INFANTS. 2091
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 326
FRC DEPENDENT INTEGRATED PRESSURE-VOLUME RELATIONSHIPS. † 1941
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 326
FRC DEPENDENT INTEGRATED PRESSURE-VOLUME RELATIONSHIPS. † 1941